Table 1 Baseline clinical and laboratorial characteristics of HD patients

Age (years)

65.0 [54.8–74.3]

59.0 [49.0–71.0]

Sex– Male (%)

107 (64.5)

154 (65.3)

Ethnicity - White British (%)

110 (66.3)

167 (70.8)

Pre HD weight (Kg)^a

73.5 [62.0–85.3]

76.2 [64.2–91.4]

BMI^b

25.8 [22.9–29.4]

27.5 [23.3–31.6]

Last URR (%)^c

71.1 [65.4–75.5]

69.3 [63.1–74.4]

Corrected Calcium^d (mmol/L)

2.36 ± 0.18

2.34 ± 0.17

Phosphate^e (mmol/L)

1.56 [1.27–1.89]

1.68 [1.33–2.07]

Parathyroid Hormone^f (pmol/L)

26.9 [12.5–56.8]

28.9 [13.2–51.9]

Haemoglobin^g (g/L)

107 ± 16.1

107 ± 17.6

Potassium^h (mmol/L)

4.50 [4.00–5.20]

4.90 [3.20–5.50]

Albuminⁱ (g/L)

38.0 [34.1–41.0]

38.5 [35.0–41.0]

Pre-HD average SBP^j

148 ± 21.7

147 ± 22.4

Pre-HD average DBP^k

74.0 [62.3–84.8]

77.5 [67.0–88.0]

Post-HD average SBP^l

139 [126–154]

137 [121–156]

Post-HD average DBP^m

72.0 [63.0–80.0]

71.5 [63.8–83.3]

Average UFⁿ (L)

1.40 [1.00–2.00]

2.00 [1.50–2.70]

Anuric Status^o (n)

16

N/A

Dialysis Vintage (months)

21 (6.3–14.5)

29.5 (11.9–261)

 Diabetic Nephropathy (%)

51 (30.7)

81 (34.3)

 Hypertensive/Renovascular disease (%)

27 (16.3)

30 (12.7)

 Glomerulonephritis (%)

21 (12.7)

31 (13.1)

 ADPKD (%)

15 (9.0)

13 (5.5)

 Urological (%)

13 (7.8)

24 (10.2)

 Pyelonephritis (%)

3 (1.8)

11 (4.7)

 ANCA-associated vasculitis (%)

4 (2.4)

5 (2.1)

 Other (%)

17 (10.2)

16 (6.8)

 Unknown (%)

15 (9.0)

25 (10.6)

 Ischaemic heart disease (%)

25 (15.1)

40 (17.0)

 Heart Failure (%)

5 (3.0)

18 (7.6)

 CVA (%)

16 (9.7)

35 (14.8)

 Diabetes Mellitus (%)

62 (37.4)

101 (42.8)

 ACEi (%)

30 (18.1)

46 (19.5)

 ARB (%)

19 (11.5)

32 (13.6)